Iams WT - Search Results

1

Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

Iams WT, Shiuan E, Meador CB, Roth M, Bordeaux J, Vaupel C, Boyd KL, Summitt IB, Wang LL, Schneider JT, Warner JL, Zhao Z, Lovly CM. Iams WT, et al. J Thorac Oncol. 2019 Nov;14(11):1970-1981. doi: 10.1016/j.jtho.2019.05.042. Epub 2019 Jun 12. J Thorac Oncol. 2019. PMID: 31201935 Free PMC article.

2

Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas.

Yu HA, Sima CS, Shen R, Kass S, Gainor J, Shaw A, Hames M, Iams W, Aston J, Lovly CM, Horn L, Lydon C, Oxnard GR, Kris MG, Ladanyi M, Riely GJ. Yu HA, et al. J Thorac Oncol. 2015 Mar;10(3):431-7. doi: 10.1097/JTO.0000000000000432. J Thorac Oncol. 2015. PMID: 25415430 Free PMC article.

3

Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies.

Johnson DB, Lovly CM, Flavin M, Panageas KS, Ayers GD, Zhao Z, Iams WT, Colgan M, DeNoble S, Terry CR, Berry EG, Iafrate AJ, Sullivan RJ, Carvajal RD, Sosman JA. Johnson DB, et al. Among authors: iams wt. Cancer Immunol Res. 2015 Mar;3(3):288-295. doi: 10.1158/2326-6066.CIR-14-0207. Cancer Immunol Res. 2015. PMID: 25736262 Free PMC article.

4

Anaplastic Lymphoma Kinase as a Therapeutic Target in Non-Small Cell Lung Cancer.

Iams WT, Lovly CM. Iams WT, et al. Cancer J. 2015 Sep-Oct;21(5):378-82. doi: 10.1097/PPO.0000000000000142. Cancer J. 2015. PMID: 26389762 Free PMC article. Review.

5

Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.

Iams WT, Lovly CM. Iams WT, et al. Clin Cancer Res. 2015 Oct 1;21(19):4270-7. doi: 10.1158/1078-0432.CCR-14-2518. Clin Cancer Res. 2015. PMID: 26429980 Free PMC article. Review.

6

Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆.

Hames ML, Chen H, Iams W, Aston J, Lovly CM, Horn L. Hames ML, et al. Lung Cancer. 2016 Feb;92:29-34. doi: 10.1016/j.lungcan.2015.11.004. Epub 2015 Nov 10. Lung Cancer. 2016. PMID: 26775593 Free PMC article.

7

Major milestones in translational oncology.

Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA. Dragani TA, et al. Among authors: iams wt. BMC Med. 2016 Jul 28;14(1):110. doi: 10.1186/s12916-016-0654-y. BMC Med. 2016. PMID: 27469586 Free PMC article.

8

Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.

Almodovar K, Iams WT, Meador CB, Zhao Z, York S, Horn L, Yan Y, Hernandez J, Chen H, Shyr Y, Lim LP, Raymond CK, Lovly CM. Almodovar K, et al. Among authors: iams wt. J Thorac Oncol. 2018 Jan;13(1):112-123. doi: 10.1016/j.jtho.2017.09.1951. Epub 2017 Sep 23. J Thorac Oncol. 2018. PMID: 28951314 Free PMC article.

9

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.

Iams WT, Lovly CM. Iams WT, et al. Cancer Discov. 2018 Jul;8(7):797-799. doi: 10.1158/2159-8290.CD-18-0489. Cancer Discov. 2018. PMID: 29967074 Free PMC article.

10

First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.

Iams WT, Yu H, Shyr Y, Patil T, Horn L, McCoach C, Kelly K, Doebele RC, Camidge DR. Iams WT, et al. Clin Lung Cancer. 2018 Nov;19(6):531-543. doi: 10.1016/j.cllc.2018.08.011. Epub 2018 Aug 22. Clin Lung Cancer. 2018. PMID: 30197261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page